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Accepted 1 July 2013Diet is one factor that plays a part in coronary heart disease risk through multiple biological
mechanisms including subclinical inflammation. In this review, we aimed to systematically
assess and summarize evidence regarding the association of saturated fatty acids (SFAs)
with inflammatory markers and adipokines. An electronic search of the literature was
conducted up to September 2010 using Medline, Scopus, Web of Science, and Science Direct
(updated from September 2010 to August 2011 through Medline). Original studies that were
written in Portuguese, English, Spanish, or French, and addressed the effects of SFA (not
dietary sources or SFA-rich diets) on inflammatory markers or adipokines in adult
populations were considered eligible. Data from 15 studies providing adjusted estimates
were extracted. The publication year varied from 1995 to 2010 and the sample size from 54 to
4900. Most studies were cross sectional, with 3 studies using a prospective design. Twelve
studies assessed total SFA, and 3 studies considered their subtypes, which were measured
through dietary assessments (11 studies) or in blood samples (4 studies). Significant positive
associations were observed between SFA and soluble intercellular adhesion molecule-1 and
interleukin-6, whereas no significant associations were observed with E-selectin, tumor
necrosis factor α, granulocyte-macrophage colony-stimulating factor, fibrinogen, and
adiponectin. For high-sensitivity C-reactive protein, 2 studies showed significant positive
associations, whereas 3 studies reported no significant associations. One study reported a
significant inverse association of SFA with leptin, although the other 3 found no significant
associations. Based on this systematic review, a potential positive association of SFA with
high-sensitivity C-reactive protein but not with adipokines is suggested, which should be
confirmed by future research.
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Long-standing public health recommendations emphasize
the importance of reducing saturated fatty acid (SFA) intake
as a means of preventing cardiovascular diseases (CVDs),
namely, coronary heart disease (CHD) [1]. The relationship of
these fatty acids with CHD risk has traditionally been
explained through their well-established effects on lipids
and lipoproteins [2]. Nevertheless, the effects of diet on CHD
seem to be mediated throughmultiple biological mechanisms
that include oxidative stress, endothelial dysfunction, insulin
sensitivity, blood pressure, thrombotic tendency, and subclin-
ical inflammation [3].
Several inflammatory markers have been suggested as
potentially useful predictors of prevalent or incident CVD,
such as cell adhesion molecules, cytokines, acute-phase
proteins, and white blood cell count [4]. According to meta-
analyses of long-term prospective studies, positive associa-
tions with CHD risk have been reported for fibrinogen [5,6],
high-sensitivity C-reactive protein (hs-CRP) [7], white blood
cell count [6], and interleukin-6 (IL-6) [8], whereas no associ-
ations have been found with soluble cell adhesion molecules
[9]. A number of adipokines—proteins produced mainly by
adipocytes [10]—are linked to inflammation and probably to
CHD also. Of these, increasing attention has been paid to the
antiinflammatory and proinflammatory effects of adiponectin
and leptin, respectively [10]. Meta-analyses of prospective
studies suggested inverse associations (for adiponectin) and
positive associations (for leptin) with CHD, but these associ-
ations were more modest than previously suspected [11,12].
Thus far, no systematic evidence on the relationship
between SFA and inflammatory outcomes has been put
forward. Therefore, by systematically reviewing and summa-
rizing evidence that addressed the effects of SFA on inflamma-
tory markers and adipokines, we aimed to understand if SFA
could influence CHD risk through an inflammatory pathway.2. Methods
2.1. Search strategy
Potentially eligible studies were identified by an electronic
search through Medline, Scopus, Web of Science, and Science
Direct databases using a search expression to identify the
exposure (“saturated fatty acids” OR “saturated fat”) combined
with a search expression to identify the outcomes of interest
(“inflammation” OR “cell adhesion molecules” OR “cytokines”
OR “interleukins” OR “tumor necrosis factor-alpha” OR “fibrin-
ogen”OR “serumamyloid A protein”OR “C-reactive protein”OR
“leukocyte count” OR “inflammation mediators” OR “adipo-
kines” OR “adiponectin” OR “resistin” OR “leptin”). To optimize
the search strategy, the syntax was adapted for each electronic
database used, and when applicable, the terms were searched
as indexed and as free-text terms. A search filter was applied to
the Medline syntax (NOT (animals [mh] NOT humans [mh])) to
retrieve only human studies. The literature search was con-
ducted until August 2011. Firstly, the electronic databases were
searched from inception up to September 2010. After deletingduplicates, the initial search yielded 1066 potentially eligible
studies, whichwere screened in a 2-stage process (based on the
reading of titles and/or abstracts and then of full text). To
standardize procedures, this 2-stage screening process was
independently conducted by 3 researchers in a subsample of 30
studies. Discrepancies in the evaluation of the studies were
resolved by unanimous agreement.
This search was supplemented by hand searching the
reference lists of original studies and reviews. A search update
was conducted in August 2011 through Medline database
(because 95% of the eligible studies identified in the main
search were retrieved from Medline), yielding 51 additional
potentially eligible studies that were also screened in the 2-
stage process that was previously described.
2.2. Exclusion criteria
The following exclusion criteria were set a priori and
considered in the 2-stage screening process: (1) nonoriginal
studies, (2) studies with data unrelated to the effects of SFA on
inflammatory markers or adipokines, (3) nonhuman/in vitro
studies, (4) nonadult population studies (<17 years old), (5)
studies that did not evaluate SFA but rather their dietary
sources or SFA-rich diets, (6) studies that did not provide the
association's estimates of SFA with inflammatory markers or
adipokines, and (7) studies that were not written in Portu-
guese, English, Spanish, or French. No studies were excluded
because of weakness of design or lack of data quality.
2.3. Data extraction
Eligible studies were reviewed, and data were extracted using a
predefined extraction form. Disagreement in the studies'
evaluation was resolved through consensus, which involved a
discussion among researchers. From each study, the following
information was extracted: first author, publication year,
country of origin, study design/analysis approach, sample
characteristics (size, sex distribution, age, and,whenapplicable,
a general description of participants), type and assessment
method of the exposure, outcome, covariates, and results. Only
adjusted estimates were extracted. When a study presented
different adjustment models, we extracted estimates from the
model consideredby theauthorsas the final one. If this criterion
could not be applied, estimates adjusted for the largest number
of possible confounding variables were considered.3. Findings of SFA on inflammation and
circulating levels of adipokines
Twenty-three studies were considered eligible, of which 21
studies were identified through both electronic searches con-
ducted [13–33] and2 studies through the reference lists searched
[34,35]. Of these, 15 studies presented adjusted estimates, and
therefore, data were extracted [13–26,35] (Fig.). The main
characteristics of these studies and the results on the associa-
tions between SFA and inflammatorymarkers or adipokines are
summarized in Tables 1–4. Studies were grouped by type of
outcome: cell adhesion molecules (Table 1), cytokines (Table 2),
acute-phase proteins (Table 3), and adipokines (Table 4).
23 Eligible studies 
2 Eligible studies identified through reference lists 
search
1 Eligible study identified through Medline database 
search (from 51 potentially eligible studies)
15 Eligible studies for which data were extracted 
1066 Potentially eligible studies identified through Medline, Scopus, 
Web of Science and Science Direct databases search
24 Potentially eligible studies
1042 Studies excluded based on title and/or abstract review, by 
this order:
334 Non original studies (e.g., systematic review, meta-
analysis, review, comment, editorial, note);
654 Studies with data unrelated to the effects of SFA on 
inflammatory markers or adipokines;
23 Non human/in vitro studies;
4 Non adult population studies;
26 Studies that did not evaluate SFA but rather their 
dietary sources or SFA-rich diets;
1 Study written in German (non-Portuguese, English, 
Spanish or French).
4 Studies excluded based on full text review, by this order:
1 Non adult population study;
3 Studies that did not provide the association’s 
estimates.
20 Eligible studies 
8 Studies excluded because adjusted estimates 
were not provided
Fig. – Systematic review flowchart.
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studies conducted in North America [13,16,17,20,21,35], 7 in
Europe [14,15,18,19,24–26], and 2 in Japan [22,23]. Most studies
were cross sectional [13,16–20,22–26,35], with 3 studies using a
prospective design [14,15,21]. The number of participants in
each study ranged from 54 to 4900. There were 4 studies
conducted exclusively in men [16,17,24,35], 3 studies con-
ducted exclusively in women [20,22,23], and 8 studies that
included both sexes [13–15,18,19,21,25,26]. The effects on
inflammatory markers and adipokines were assessed in 12
studies for total SFA [13–17,19–24,35] and in 3 studies for their
subtypes [18,25,26]. Dietary assessments were used in 11
studies and included 24-hour recalls [13], food frequency
questionnaires (FFQs) [14–16,20,21,35], food records [17], and
dietary histories [22–24]. The other 4 studies measured fatty
acids in blood samples [18,19,25,26]. The statistical analysisconducted, as well as the level of adjustment performed,
varied across studies.3.1. Cell adhesion molecules
Three studies on SFA and cell adhesion molecules were
included and focused on soluble intercellular adhesion
molecule-1 (sICAM-1), soluble vascular cellular adhesion
molecule-1 (sVCAM-1), and E-selectin (Table 1). There was a
significant trend between quintiles of change in the percent-
age of energy intake from SFA and changes in sICAM-1
concentration after 2 years of follow-up (P for trend < .001) in
moderately hypercholesterolaemic Dutch subjects with at
least 2 of the following cardiovascular risk factors: high blood
pressure (diastolic ≥95 mm Hg and/or systolic ≥160 mm Hg) or
Table 1 – Studies on SFAs and cell adhesion molecules included in this systematic review
First author,
publication
year, country
of origin
Study
design/
analysis
approach
Sample
characteristics
Exposure Outcome Covariates Results
Type Assessment
method
Bemelmans
[14], 2002,
the Netherlands
Before-
and-after
analysis
103 (37% men);
age range, 30-70
y; subjects with
elevated risk at
developing
CVDs
SFA Semiquantitative
FFQ (reference
period unknown)
sICAM-1 Baseline sICAM-1
concentration, BMI and
SFA intake, age and
changes in intake of fruit,
polyunsaturated fat, and
dietary cholesterol
Mean (SEM) of
changes in sICAM-1
concentration per
quintile of change in
the % of energy intake
from SFA (mean [SD])
after 2 y
Q1 (−5.9 [1.4]):
−19.0 (5.6)
Q2 (−2.7 [0.4]):
−12.7 (4.9)
Q3 (−1.7 [0.3]):
−2.0 (4.8)
Q4 (−0.3 [0.5]): 5.6 (5.0)
Q5 (1.6 [0.7]): 8.6 (5.3)
P for trend < .001;
n = 78
Couillard [17],
2006, Canada
Cross
sectional
54 men; mean
(SD) age, 40 y
(12); apparently
healthy but
abdominally
obese
SFA 3-d food record (2
weekdays and 1
weekend day)
sICAM-1,
sVCAM-1
Age, BMI, waist-to-hip
ratio, abdominal visceral
adipose tissue area,
dietary monounsaturated
and polyunsaturated fat
intakes, cholesterol, total
daily energy,
carbohydrate intakes
Partial (R2 * 100);
P value:
sICAM-1 8.87; .0320
sVCAM-1 8.82; .0325
Petersson [25],
2009, Sweden
Cross
sectional
264 (56% men);
age, 70 y
Myristic
acid
(14:0);
palmitic
acid
(16:0);
stearic
acid (18:0)
Measured in
serum
cholesteryl
esters
E-selectin BMI, smoking habits,
alcohol consumption,
physical activity, use of
lipid lowering drugs
P value:
Myristic acid: .77
Palmitic acid: .54
Stearic acid: .31
n = 211
R2, coefficient of determination.
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≥27 kg/m2, smoking, history of CVD, and/or family history of
onset of CVD before the age of 60 years. In the first quintile
(corresponding to a decrease of 5.9% of energy intake fromSFA),
the sICAM-1 concentration decreased 19.0 ng/mL (SEM = 5.6)Table 2 – Studies on SFAs and cytokines included in this system
First author,
publication
year, country
of origin
Study
design/
analysis
approach
Sample characteristics Expo
Type
Kalogeropoulos
[19], 2010, Greece
Cross
sectional
374 (51% men); mean (SD)
age: men, 44 y (13);
women, 40 y (15);
apparently healthy
SFA M
p
Fernández-Real
[18], 2001, Spain
Cross
sectional
78 (49% men); mean (SD)
age: men, 40.1 y (13.3);
women, 38.1 y (9.3)
Palmitic
acid (16:0)
M
s
β, regression coefficient.compared with an increase of 8.6 ng/mL (SEM = 5.3) in the fifth
quintile (corresponding to an increase of 1.6% of energy intake
from SFA) [14]. In another study [17], the intake of SFA was
the best predictor of the variance in circulating sICAM-1 (P =
.0320) and sVCAM-1 (P = .0325) concentrations in apparentlyatic review
sure Outcome Covariates Results
Assessment
method
easured in
lasma
IL-6;
TNF-α
Age, sex, smoking habits,
physical activity status,
energy intake,
dietary habits through
the MedDietScore, BMI
β ± SE
(P value):
IL-6: 0.02 ±
0.008 (.01)
TNF-α: 0.17 ±
0.10 (.08)
easured in
erum
GM-CSF Not specified In women:
β (P value):
0.0011 (.99)
Table 3 – Studies on SFAs and acute-phase proteins included in this systematic review
First author,
publication
year, country
of origin
Study
design/
analysis
approach
Sample
characteristics
Exposure Outcome Covariates Results
Type Assessment
method
King [13],
2003, USA
Cross
sectional
4900 men and
women; age
range, ≥17 y
SFA 24h recall (1 day) hs-CRP Age, race, sex,
medication for diabetes
and for lowering
cholesterol, smoking,
BMI, alcohol
consumption, exercise,
total caloric intake
OR (95% CI) of
elevated hs-CRP
(>3.0mg/L) risk for
each quartile of SFA
relative to the lowest
quartile
Q3 vs Q1: 1.58 (1.02 to
2.44)
Q4 vs Q1: 1.44 (0.80 to
2.58)
Kalogeropoulos
[19], 2010, Greece
Cross
sectional
374 (51% men);
mean (SD) age:
men, 44 y (13);
women, 40 y
(15); apparently
healthy
SFA Measured in
plasma
hs-CRP;
fibrinogen
Age, sex, smoking
habits, physical activity
status, energy intake,
dietary habits through
the MedDietScore, BMI
β ± SE (P value)
hs-CRP: 0.11 ± 0.04
(.008)
Fibrinogen: 0.003 ±
1.16 (.99)
Murakami [22],
2008, Japan
Cross
sectional
443 women; age
range, 18-22 y;
healthy and
lean; hs-CRP <10
mg/L
SFA Diet history
questionnaire (1
mo)
hs-CRP Residential block, size of
residential area, current
smoking, alcohol
drinking, dietary
supplement use,
physical activity, BMI
OR (95% CI) of
elevated hs-CRP (≥1.0
mg/L) risk for SFA
intake above vs below
the median value
(8.3% of energy): 1.22
(0.52-2.83)
Bo [15] , 2008,
Italy
Before-
and-after
analysis
335 (42% men);
mean (SD) age,
56 y (6); subjects
with multiple
metabolic
abnormalities
SFA Semiquantitative
FFQ (reference
period unknown)
hs-CRP Age, sex, actual BMI Effect of increased
SFA intake on
changes in hs-CRP
after 1 y: β (95% CI), P
value: 0.02 (−0.001 to
0.04), .10
Petersson [25],
2009, Sweden
Cross
sectional
264 (56% men);
age, 70 y; hs-CRP
≤10 mg/L
Myristic
acid (14:0);
palmitic
acid (16:0);
stearic
acid (18:0)
Measured in
serum
cholesteryl
esters
hs-CRP BMI, smoking habits,
alcohol consumption,
physical activity, use of
lipid lowering drugs
P valuea:
Myristic acid: .58
Palmitic acid: .51
Stearic acid: .02
n = 211
Ludwig [21],
1999, USA
Cohort
study
1453 (white men
and women);
1132 (black men
and women)
SFA Quantitative FFQ
(1 mo)
Fibrinogen Sex, age, field center,
education, energy
intake, physical activity,
cigarette smoking,
alcohol intake, vitamin
supplement use
Fibrinogen means
(mg/dL) according to
quintiles of SFA
For white men and
women: Q1 = 251, Q5 =
258; P for trend = .18
For black men and
women: Q1 = 270, Q5 =
273; P for trend = .34
Pekkanen [24],
1995, Finland
Cross
sectional
198 men; age
range: 70-89 y
SFA Dietary history
method (1 mo)
Fibrinogen Age, dietary energy Partial spearman rank
correlation: −0.02
β, Regression coefficient.
a P < .01 was considered statistically significant to avoid type 1 errors caused by multiple testings.
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hepatic, and renal disorders and proinflammatory conditions,
as well as nonsmokers, alcohol intake less than 30 g/d, and
body weight changes less than 3 kg within 2 months before
the study. As a group though, men who took part in this
study were obese and characterized by an important
accumulation of abdominal and visceral adipose tissue.
However, in another study based on an elderly Swedish
population, no significant associations between E-selectin
and myristic acid (P = .77), palmitic acid (P = .54), or stearicacid (P = .31) that were measured in serum cholesteryl esters
were reported [25].
3.2. Cytokines
Two studies on SFA and cytokines were included and have
focused on IL-6, tumor necrosis factor α (TNF-α), and
granulocyte-macrophage colony-stimulating factor (GM-CSF)
(Table 2). Total plasma SFA presented a significant positive
association with circulating IL-6 (β = 0.02, P = .01), whereas a
Table 4 – Studies on SFAs and adipokines included in this systematic review
First author,
publication
year, country
of origin
Study
design/
analysis
approach
Sample
characteristics
Exposure Outcome Covariates Results
Type Assessment
method
Murakami
[23], 2007,
Japan
Cross
sectional
424 women; age
range, 18-22 y;
healthy and lean
SFA Diet history
questionnaire
(1 mo)
Leptin Residential block, size of
residential area, current
smoking, rate of eating,
alcohol drinking, physical
activity, energy intake, BMI,
intakes of protein, dietary
fiber, monounsaturated and
polyunsaturated fatty acids
Geometric
means (95%
CI) for
leptin
according
to quintiles
of SFA:
Q1: 7.8
(7.0-8.7)
Q2: 7.3
(6.6-7.9)
Q3: 7.6
(7.0-8.3)
Q4: 8.1
(7.5-8.9)
Q5: 7.6
(6.8-8.5)
P for
trend = .88
Kong [20],
2009, USA
Cross
sectional
173 women; age
range, 50-75 y;
overweight to
obese
postmenopausal
and sedentary
SFA Semiquantitative
FFQ (3 mo)
Leptin Energy intake, BMI,
percentage body fat, age and
intra-abdominal fat
β (P value):
0.10 (.12)
n = 162
Chu [16],
2001, USA
Cross
sectional
268 men; age
range, 47-83 y
SFA Semiquantitative
FFQ (1 y)
Leptin Age, cigarette smoking,
alcohol drinking, physical
activity, time since last meal,
BMI, total calories, total
protein, monounsaturated,
polyunsaturated and
cholesterol intake
β ± SE (P
value): −
0.41 ± 0.75
(.581)
Warensjo [26],
2004, Sweden
Cross-
sectional
analysis
234 (80% men);
mean (SD) age,
55 y (7)
Pentadecanoic
acid (15:0) +
heptadecanoic
acid (17:0)
Measured in
serum
phospholipids
Leptin BMI Pearson
correlation
coefficient;
P value: −
0.20; <.05
Pischon [35],
2005, USA
Cross
sectional
532 men; mean
(SD) age, 65.2 y
(0.4)
SFA Semiquantitative
FFQ (1 y)
Adiponectin Age, smoking status, history
of diabetes, history of
hypertension, alcohol
consumption, physical
activity, energy intake,
protein, monounsaturated
and polyunsaturated fat, BMI
β ± SE (P
value): 1.65
± 1.17 (.16)
β, regression coefficient.
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TNF-α (β = 0.17, P = .08) in apparently healthy Greek adults
(without any clinical evidence of CVD, any other atheroscle-
rotic disease, cancer, or chronic viral infections) [19]. Serum
palmitic acid exhibited a nonsignificant association with GM-
CSF (β = 0.0011, P = .99) in Spanish women; no adjusted
estimates were shown in men [18].
3.3. Acute-phase proteins
Seven studies on SFA and acute-phase proteins were included
and focused on hs-CRP and fibrinogen (Table 3). An increasedlikelihood of elevated hs-CRP (>3.0 mg/L) was found for the
third quartile of SFA intake in United States (US) adults (odds
ratio [OR], 1.58; 95% confidence interval [CI], 1.02-2.44) [13]. For
total SFA measured in plasma of the aforementioned appar-
ently healthy Greek adults, a significant positive association
was also reported with hs-CRP (β = 0.11, P = .008) [19]. On the
contrary, in young healthy (without diabetes mellitus, hyper-
tension, and CVD) and lean Japanese women, SFA intake
above the median value (8.3% of energy) was not sig-
nificantly associated with an increased likelihood of elevated
hs-CRP (≥1.0 mg/L; OR, 1.22; 95% CI, 0.52-2.83) [22]. Similarly, in
another study, an increased SFA intake was not significantly
693N U T R I T I O N R E S E A R C H 3 3 ( 2 0 1 3 ) 6 8 7 – 6 9 5associated with changes in hs-CRP (β = 0.02, P = .10) in Italian
subjects withmultiplemetabolic abnormalities (with either the
metabolic syndrome or 2 components of the syndrome plus hs-
CRP serum values of ≥3.0 mg/L) but without diabetes mellitus,
CVD, chronic liver or kidney disease, and advanced cancer [15].
High-sensitivity CRP was also not significantly associated with
myristic acid (P = .58), palmitic acid (P = .51), or stearic acid (P =
.02) that were measured in serum cholesteryl esters of the
Swedish elderly population thatwas previouslymentioned [25].
For fibrinogen, total plasma SFA exhibited a nonsignificant
association (β = 0.003, P = .99) [19]. Also, nonsignificant trends of
fibrinogen concentration across quintiles of SFA intake were
reported in white (P for trend = .18) and black US adults (P for
trend = .34) [21]. No correlation between SFA intake and
fibrinogen was found in elderly Finnish men (r = −0.02) [24].
3.4. Adipokines
Five studies on SFA and adipokines were included and have
focused on leptin and adiponectin (Table 4). There was no
significant trend between quintiles of SFA intake and leptin
concentrations in the previously mentioned population of
young healthy and lean Japanese women (P for trend = .88)
[23]. Also, intake of SFA was not significantly associated with
leptin concentrations (β = 0.10, P = .12) in a group of
overweight to obese (BMI of at least 25.0 kg/m2 or a BMI
≥24.0 and <25.0 kg/m2 if percentage body fat >33.0%)
postmenopausal and sedentary US women [20]. In a group
of US men aged 47 to 83 years (who were free of CVD, diabetes
mellitus, gastric or duodenal ulcer, liver disease, and cancer—
except nonmelanoma skin cancer), SFA intake was also not
significantly associated with leptin concentrations (β = −0.41,
P = .581) [16]. Only the sum of pentadecanoic acid and
heptadecanoic acid in serum phospholipids of a Swedish
population was significantly and negatively correlated with
leptin (r = −0.20, P < .05), but the correlation's magnitude was
poor [26]. In regard to adiponectin, a nonsignificant association
with SFA intake (β = 1.65, P = .16) was found in US men [35].4. Discussion
This systematic review sought to evaluate the effects of SFA on
inflammatorymarkers and adipokines providing a summary of
theavailableevidenceon this topic.Overall, datawereextracted
and summarized for sICAM-1, sVCAM-1, E-selectin, IL-6, TNF-α,
GM-CSF, hs-CRP, fibrinogen, leptin, and adiponectin.
In 78 Dutch subjects with elevated risk of developing CVD,
an increased intake of SFA was associated with increased
concentrations of sICAM-1 [14], thus suggesting a detrimental
role of SFA on endothelial function. However, in this high-risk
population, the sICAM-1 concentrations might be a conse-
quence of an asymptomatic arterial disease, therefore con-
founding the association with SFA intake. Also, in a group of
54 apparently healthy but abdominally obese Canadian men,
SFA intakewas the best predictor of the variance in circulating
sICAM-1 and sVCAM-1 concentrations [17]. However, because
the magnitude and direction of the associations were
unknown, clear conclusions could not be drawn from these
findings. In contrast, no associations were found betweenmyristic, palmitic, or stearic acids measured in serum
cholesteryl esters and E-selectin in 211 Swedish elderly men
and women [25]. Nevertheless, the possibility of existing
associations in other populations, namely, in those including
younger subjects, cannot be excluded.
Very few studies evaluated the association between SFA
and cytokines, yielding inconclusive findings. Total SFA
measured in the plasma of 374 apparently healthy Greek
adults were positively associated with circulating IL-6 but not
with TNF-α [19]. In Spanish women, no associations were
observed between serum palmitic acid and GM-CSF [18]. It
should be stressed that only 40 women were included in this
analysis, and therefore, even if there is an association
between palmitic acid and GM-CSF, statistical power may
have been insufficient to allow its detection.
Studies on SFA and hs-CRP included in this systematic
review have shown inconsistent findings. On one hand, intake
of SFAwas associated with an increased likelihood of elevated
hs-CRP (>3.0 mg/L) in a study of US adults that presented the
largest sample size (n = 4900) [13]. Likewise, total plasma SFAs
were positively associated with circulating hs-CRP in the
population of apparently healthy Greek adults [19]. On the
other hand, SFA intake was not significantly associated with
an increased likelihood of elevated hs-CRP (≥1.0 mg/L) in 443
young healthy and lean Japanese women. The authors
suggested that the absence of association could be caused by
the low base rate of elevated hs-CRP concentrations (5.6%) [22].
The use of different cutoff values for defining elevated hs-CRP in
this study of young Japanese women (≥1.0 mg/L) and in the
previously mentioned study of US adults (>3.0 mg/L) did not
allow strict comparisons between both studies. Also, in 335
Italian subjects with multiple metabolic abnormalities, in-
creasedSFAintakewasnot significantlyassociatedwithchanges
in hs-CRP. The authors hypothesized that in dysmetabolic
subjects, the role of dietary factors such as SFA on inflammation
could be less evident than in healthy subjects [15]. Lastly, no
associations were found between levels of myristic, palmitic, or
stearic acids in serum cholesteryl esters and circulating hs-CRP
in a Swedish elderly population [25]. As stated for E-selectin, the
associations between these SFA subtypes and hs-CRP should
also be studied in younger subjects. With respect to fibrinogen,
no associations were observed regarding the effects of total SFA,
measured either in plasma or in diet [19,21,24].
Intake of SFA was not significantly associated with leptin
concentrations in 424 young healthy and lean Japanese
women [23]. The narrower range of leptin concentration in
this population could have contributed, at least partly, to this
lack of association. Similarly, in 173 overweight to obese
postmenopausal and sedentary US women [20], as well as in
268 US men aged 47 to 83 years [16], no associations were
found between SFA intake and leptin concentrations. Only
the sum of pentadecanoic acid and heptadecanoic acid in
serum phospholipids of 234 Swedish men and women was
significantly and negatively correlated with leptin; however,
the magnitude of the correlation was poor [26]. It is possible
that, because the study only adjusted for BMI, uncontrolled
confounding may exist, and therefore, this relationship may
be prone to bias. Further data from one study revealed a
nonsignificant association with SFA intake and adiponectin
in 532 US men [35].
694 N U T R I T I O N R E S E A R C H 3 3 ( 2 0 1 3 ) 6 8 7 – 6 9 5Although no clear associations were reported in the
literature, a possible association between SFA and inflam-
matory markers or adipokines could be supported, at least to
some extent, by biological mechanisms. It seems that SFAs
stimulate inflammatory signaling pathways by a process
that involves toll-like receptor 4 [36] and, subsequently,
nuclear factor κB, thus increasing the expression of a
number of inflammatory genes [37–41]. A novel mechanism
by which SFA might greatly amplify macrophages inflam-
mation through a toll-like receptor 4–independent pathway
has been proposed, which is dependent on the uptake and
metabolic processing of SFA into ceramide [42]. The effects
of SFA on adipokines seem to be mediated by the nuclear
receptor peroxisome proliferator–activated receptor-γ
(PPAR-γ). Pharmacologic activation with PPAR-γ agonists
leads to increased plasma adiponectin [43,44] and decreased
plasma leptin concentrations [45]. Saturated fatty acids are
thought to bind and inhibit PPAR-γ. In fact, it has been
shown that dietary SFAs decrease the levels of arachidonic
acid - the precursor for the PPAR-γ ligands - in adipocyte
plasma membrane phospholipids [46] or could be involved
in a possible impairment in ligand-dependent activity of
PPAR-γ [47].
As in other systematic reviews, the conclusions reached by
this study depend on other factors, for example, the compre-
hensive nature of the search strategy and the criteria used for
inclusion or exclusion of studies and data extraction. Further-
more, the availability of relevant studies in the literature is, in
part, a limiting factor.
In this review, the temporal sequence of the reported
associations cannot be completely established because of the
cross-sectional nature of most studies. However, reverse
causality seemed unlikely to affect our conclusions because
it was not expected that the exposures changed due to the
outcomes and subclinical concentrations of inflammatory
markers and adipokines are quite stable in time. Moreover,
the statistical power may have been insufficient to allow the
detection of significant associations owing to the relatively
small sample size of most studies.
The differences across the specific populations investigat-
ed (eg, abdominally obese, elderly populations, and dysmeta-
bolic subjects) could be pointed out as another limitation,
thus complicating straight comparisons across the studies.
Different findings might be found in other populations,
particularly in healthy ones or in those that included younger
subjects. The comparisons were also compromised by the
different adjustments performed. However, most studies
adjusted for energy intake either by the nutrient density
method or by including energy intake as a covariate in
the analysis.
Another drawback of this systematic review was its
reliance on the accuracy of dietary assessments. Food
frequency questionnaires are the method of choice in most
studies, perhaps because they are inexpensive and can assess
long-term diets [48]; however, this method is also subject to
random and systematic errors. Only 4 studies provided amore
objective measure of SFA exposure by directly measuring
them in blood samples. However, when possible to compare,
we did not find differences in results according to the type of
method used—dietary reporting vs biomarkers.Finally, the few studies available for review for each type of
outcome precluded definite statements on the studied
associations. In conclusion, this systematic review suggests
a potential positive association of SFA with hs-CRP but does
not support an association with adipokines. Further studies
are needed in this poorly investigated field.Acknowledgment
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